Hoth Therapeutics, Inc.

NasdaqCM:HOTH Stock Report

Market Cap: US$5.4m

Hoth Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:HOTH Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Aug 24BuyUS$16,750Robb KnieIndividual25,000US$0.67

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HOTH?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders65,5870.95%
Institutions366,4985.31%
General Public6,471,71993.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 58.8%.

Top Shareholders

Top 18 shareholders own 6.26% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
1.77%
Hudson River Trading LLC, Asset Management Arm
121,947US$96.0k0%no data
1.2%
Geode Capital Management, LLC
82,908US$65.2k132%no data
0.84%
Robb Knie
58,131US$45.7k75.5%no data
0.82%
UBS Asset Management AG
56,464US$44.4k30.2%no data
0.56%
The Vanguard Group, Inc.
38,804US$30.5k0%no data
0.47%
Virtu Financial LLC, Asset Management Arm
32,636US$25.7k0%no data
0.27%
Two Sigma Securities, LLC, Asset Management Arm
18,630US$14.7k0%no data
0.15%
Morgan Stanley, Investment Banking and Brokerage Investments
10,320US$8.1k3.12%no data
0.074%
Jeff Pavell
5,075US$4.0k0%no data
0.065%
Tower Research Capital Europe Limited
4,481US$3.5k-40.5%no data
0.018%
Graig Springer
1,247US$981.30%no data
0.014%
David Sarnoff
1,000US$786.70%no data
0.0035%
Brewin Dolphin Wealth Management Limited
240US$189.10%no data
0.0019%
Wayne Linsley
134US$105.40%no data
0.00081%
Bank of America Corporation, Asset Management Arm
56US$44.060%no data
0.00013%
Osaic Wealth, Inc. , Asset Management Arm
9US$7.10%no data
0.00003%
Wells Fargo & Company, Securities and Brokerage Investments
2US$1.60%no data
0.00001%
Planned Solutions Financial & Insurance Services, Inc.
1US$0.50%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 23:11
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hoth Therapeutics, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Jason KolbertD. Boral Capital LLC.
Raghuram SelvarajuH.C. Wainwright & Co.